TY  - GEN
AU  - Ballow,M
AU  - Berger,M
AU  - Bonilla,F A
AU  - Buckley,R H
AU  - Cunningham-Rundles,C H
AU  - Fireman,P
AU  - Kaliner,M
AU  - Ochs,H D
AU  - Skoda-Smith,S
AU  - Sweetser,M T
AU  - Taki,H
AU  - Lathia,C
TI  - Pharmacokinetics and tolerability of a new intravenous immunoglobulin preparation, IGIV-C, 10% (Gamunex, 10%)
SN  - 0042-9007
PY  - 2003///1223
KW  - Adult
KW  - Asthenia
KW  - chemically induced
KW  - Caprylates
KW  - Female
KW  - Glycine
KW  - Half-Life
KW  - Humans
KW  - Immunoglobulins, Intravenous
KW  - pharmacokinetics
KW  - Immunologic Deficiency Syndromes
KW  - complications
KW  - Male
KW  - Maltose
KW  - Pharmacokinetics
KW  - Therapeutic Equivalency
KW  - Treatment Outcome
N1  - Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial
UR  - https://doi.org/10.1046/j.1423-0410.2003.00286.x
ER  -